Isocitrate Dehydrogenase 3 (NAD+) alpha (IDH3A) Peptide
-
- Target See all IDH3A products
- IDH3A (Isocitrate Dehydrogenase 3 (NAD+) alpha (IDH3A))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-IDH3A antibody (Catalog #: ARP42237_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- IDH3A (Isocitrate Dehydrogenase 3 (NAD+) alpha (IDH3A))
- Synonyms
- idh3a Peptide, MGC76128 Peptide, IDH3A Peptide, zgc:56380 Peptide, zgc:85631 Peptide, BG1 Peptide, 1110003P10Rik Peptide, 1500012E04Rik Peptide, AA407078 Peptide, AI316514 Peptide, isocitrate dehydrogenase 3 (NAD+) alpha Peptide, isocitrate dehydrogenase 3 (NAD(+)) alpha Peptide, isocitrate dehydrogenase 3 (NAD+) alpha S homeolog Peptide, idh3a Peptide, IDH3A Peptide, idh3a.S Peptide, Idh3a Peptide
- Background
-
Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. NAD(+)-dependent isocitrate dehydrogenases catalyze the allosterically regulated rate-limiting step of the tricarboxylic acid cycle. Each isozyme is a heterotetramer that is composed of two alpha subunits, one beta subunit, and one gamma subunit. IDH3A is the alpha subunit of one isozyme of NAD(+)-dependent isocitrate dehydrogenase.Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. NAD(+)-dependent isocitrate dehydrogenases catalyze the allosterically regulated rate-limiting step of the tricarboxylic acid cycle. Each isozyme is a heterotetramer that is composed of two alpha subunits, one beta subunit, and one gamma subunit. The protein encoded by this gene is the alpha subunit of one isozyme of NAD(+)-dependent isocitrate dehydrogenase.
Protein Interaction Partner: IDH3B,IDH3G,SUMO4,DMWD
Protein Size: 366 - Molecular Weight
- 40 kDa
- Gene ID
- 3419
- NCBI Accession
- NM_005530, NP_005521
- UniProt
- P50213
-